GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+6.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$342M
AUM Growth
+$342M
(-8.5%)
Cap. Flow
-$54.2M
Cap. Flow
% of AUM
-15.86%
Top 10 Holdings %
Top 10 Hldgs %
37.58%
Holding
84
New
21
Increased
8
Reduced
21
Closed
21
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$12.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$12.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
$8.38M |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$8.22M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$12.7M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$9.86M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$9.84M |
| 4 |
Merck
MRK
|
$9.53M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.42M |
Sector Composition
| 1 | Healthcare | 82.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
| $15.6M | 3.24% | 190,000 +15,000 | +9% | +$1.23M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $15.5M | 3.23% | 300,000 +100,000 | +50% | +$5.17M |
|
|
DBVT
3
DBV Technologies
DBVT
$264M
| $15.2M | 3.15% | 425,000 -75,000 | -15% | -$2.68M |
|
4
Puma Biotechnology
PBYI
$254M
| $13.1M | 2.73% | 150,000 -75,000 | -33% | -$6.56M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $12.5M | 2.6% | +125,000 | New | +$12.5M |
|
|
NVRO
6
DELISTED
NEVRO CORP.
NVRO
| $12.3M | 2.55% | +165,000 | New | +$12.3M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.2M | 2.53% | +100,000 | New | +$12.2M |
|
|
PTLA
8
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.2M | 2.34% | 200,000 | – | – |
|
|
IMMU
9
DELISTED
Immunomedics Inc
IMMU
| $10.6M | 2.2% | 1,200,000 -300,000 | -20% | -$2.65M |
|
10
Zimmer Biomet
ZBH
$21B
| $10.3M | 2.14% | 80,000 -20,000 | -20% | -$2.57M |
|
|
GNMK
11
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.76M | 2.03% | 825,000 +175,000 | +27% | +$2.07M |
|
|
ENDP
12
DELISTED
Endo International plc
ENDP
| $8.38M | 1.74% | +750,000 | New | +$8.38M |
|
|
JUNO
13
DELISTED
Juno Therapeutics, Inc.
JUNO
| $8.22M | 1.71% | +275,000 | New | +$8.22M |
|
14
Insmed
INSM
$28.8B
| $8.15M | 1.69% | +475,000 | New | +$8.15M |
|
|
ACOR
15
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.88M | 1.64% | 400,000 +100,000 | +33% | +$1.97M |
|
|
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
| $7.69M | 1.6% | 100,000 -20,000 | -17% | -$1.54M |
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| $7.67M | 1.59% | 275,000 -75,000 | -21% | -$2.09M |
|
18
Enanta Pharmaceuticals
ENTA
$180M
| $7.2M | 1.5% | 200,000 -100,000 | -33% | -$3.6M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $6.99M | 1.45% | +50,000 | New | +$6.99M |
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $6.9M | 1.43% | 150,000 -150,000 | -50% | -$6.9M |
|
|
NXTM
21
DELISTED
NxStage Medical Inc.
NXTM
| $6.52M | 1.35% | 260,000 +60,000 | +30% | +$1.5M |
|
22
Invesco CurrencyShares British Pound Sterling Trust
FXB
$91M
| $6.46M | 1.34% | +50,900 | New | +$6.46M |
|
23
iRhythm Technologies
IRTC
$5.46B
| $6.37M | 1.32% | +150,000 | New | +$6.37M |
|
|
ENTL
24
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $6.21M | 1.29% | 375,000 | – | – |
|
|
NVDQ
25
DELISTED
Novadaq Technologies Inc.
NVDQ
| $5.86M | 1.22% | 500,000 -400,000 | -44% | -$4.69M |
|